<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03630900</url>
  </required_header>
  <id_info>
    <org_study_id>Ibnsina IVF-Oxygen</org_study_id>
    <nct_id>NCT03630900</nct_id>
  </id_info>
  <brief_title>Sequential Versus Single O2 Levels on Human Embryo Development</brief_title>
  <official_title>5% O2 or Lower is the Ideal Tension for Culturing Human Embryo Development From Day 3 Onward</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ibn Sina Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Banoon IVF Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ibn Sina Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Myriads of elements affect human embryo culture in vitro. These include, but not limited to,
      air quality, culture media, culture temperature, incubator humidity, pH, and O2 levels. O2
      tension has been thoroughly investigated and, to date, 5% O2 level is superior to 20%.
      Reports showed that lowering the O2 from Day 3 of embryo culture seems to be physiological.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 24, 2018</start_date>
  <completion_date type="Actual">July 1, 2019</completion_date>
  <primary_completion_date type="Actual">June 20, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ongoing Implantation rate</measure>
    <time_frame>three months</time_frame>
    <description>number of sacs with a heartbeat after week twelve of gestation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>clinical and ongoing pregnancies</measure>
    <time_frame>three months</time_frame>
    <description>registered pregnancy with fetal heartbeat at week four after transfer and after week twelve of gestation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>human embryo development in vitro</measure>
    <time_frame>three months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">487</enrollment>
  <condition>Embryo Culture</condition>
  <arm_group>
    <arm_group_label>Sequential O2 culture (5% then 2.5%)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Embryo culture from day 0 to 3 in 5% O2 then split to either 5% or 2.5% O2 until Day 5 or 6.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>5% O2 culture</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sequential O2 Culture</intervention_name>
    <description>We investigate the effect of sequential O2 levels on human embryo culture after Intracytoplasmic sperm injection (ICSI)</description>
    <arm_group_label>Sequential O2 culture (5% then 2.5%)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ICSI cycles undergoing their first ICSI attempt

        Exclusion Criteria:

          -  ICSI cycles with a previous failure
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Banon Assiut</name>
      <address>
        <city>Assiut</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Qena Fertility Center</name>
      <address>
        <city>Qena</city>
        <zip>123456</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IbnSina IVF Center</name>
      <address>
        <city>Sohag</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>August 10, 2018</study_first_submitted>
  <study_first_submitted_qc>August 10, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 15, 2018</study_first_posted>
  <last_update_submitted>July 14, 2019</last_update_submitted>
  <last_update_submitted_qc>July 14, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ibn Sina Hospital</investigator_affiliation>
    <investigator_full_name>Muhammad Fawzy</investigator_full_name>
    <investigator_title>IVF Lab Director</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

